126912-70-7 Usage
General Description
2,3,4,5-Tetrahydro-8-methoxy-1H-pyrido[4,3-b]indole is a chemical compound that belongs to the pyridoindole class of molecules. It is a derivative of indole, containing a pyridine ring fused to the indole ring system. 2,3,4,5-TETRAHYDRO-8-METHOXY-1H-PYRIDO[4,3-B]INDOLE is a tetrahydro derivative, meaning it contains four hydrogen atoms on the pyridoindole ring. Additionally, it has a methoxy group attached to the eighth carbon atom of the pyridoindole ring. These structural features give 2,3,4,5-tetrahydro-8-methoxy-1H-pyrido[4,3-b]indole unique pharmacological properties, making it potentially useful in drug development for various therapeutic applications.
Check Digit Verification of cas no
The CAS Registry Mumber 126912-70-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,6,9,1 and 2 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 126912-70:
(8*1)+(7*2)+(6*6)+(5*9)+(4*1)+(3*2)+(2*7)+(1*0)=127
127 % 10 = 7
So 126912-70-7 is a valid CAS Registry Number.
InChI:InChI=1/C12H14N2O/c1-15-8-2-3-11-9(6-8)10-7-13-5-4-12(10)14-11/h2-3,6,13-14H,4-5,7H2,1H3
126912-70-7Relevant articles and documents
Guanidine derivative and application thereof
-
Paragraph 0559; 0564-0566, (2020/06/09)
The invention relates to a guanidine derivative serving as a VAP-1 inhibitor and application of the guanidine derivative, and further relates to a pharmaceutical composition containing the compound. The compound or the pharmaceutical composition can be us
Aryl substituted aminotetrahydropyran compound and use thereof
-
, (2019/07/04)
The invention relates to an aryl substituted aminotetrahydropyran compound and use thereof, and further relates to a pharmaceutical composition comprising the compound. The compound or pharmaceuticalcomposition provided by the invention can be used as a dipeptidyl peptidase-IV (DPP-IV) inhibitor.
CARBOLINE COMPOUNDS USABLE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES
-
Page/Page column 24, (2015/01/16)
The present invention relates to a compound according to Formula (A) or a pharmaceutically acceptable salt, solvate, clathrate, hydrate or polymorph thereof, and its use.